Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Caroline Hebert is active.

Publication


Featured researches published by Caroline Hebert.


Journal of Clinical Investigation | 1991

Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin.

Walter C. Darbonne; Glenn C. Rice; Margorie A. Mohler; Ted Apple; Caroline Hebert; Anthony J. Valente; Joffre Baker

IL-8 (also known as neutrophil-activating peptide 1) is recognized as a potent effector of neutrophil functions. Several different cell types that contact blood, namely T lymphocytes, monocytes, and endothelial cells, secrete this polypeptide following stimulation by cytokines, or lipopolysaccharide. Here we show that when IL-8 is added to blood it rapidly partitions from the plasma fluid to the blood cells and that erythrocytes account for the vast majority of this binding. Analysis of 125I-IL-8 binding [( ala-IL-8]77 form) to human red cells indicates a single, 5 nM Kd affinity class of binding sites, present at approximately 2,000 per red cell representing approximately 15 nmol of red cell IL-8 binding sites per liter of blood. These sites are protease sensitive. Their binding of IL-8 is rapidly reversible and does not result in receptor internalization, although bound IL-8 is resistant to extraction by pH 3 buffer at 5 degrees C. 125I-IL-8 binding to red cells was not inhibited by epidermal growth factor or interleukin 1, but was inhibited by monocyte chemotactic peptide-1, which is not a neutrophil chemotaxin, but is a member of the same family of polypeptides as IL-8. FACS analysis of IL-8-mediated mobilization of Ca2+ in neutrophils indicates that the IL-8 bound to red cells is incapable of stimulating neutrophils. Thus, red cell absorption of IL-8 may function to limit stimulation of leukocytes by IL-8 released into blood.


Journal of Biological Chemistry | 1996

Diverging Signal Transduction Pathways Activated by Interleukin 8 (IL-8) and Related Chemokines in Human Neutrophils IL-8 AND Gro-α DIFFERENTIALLY STIMULATE CALCIUM INFLUX THROUGH IL-8 RECEPTORS A AND B

Bassam B. Damaj; Kuldeep Neote; Caroline Hebert; Paul H. Naccache

Interleukin 8 (IL-8) and Gro-α are members of the CXC branch of a family of cytokines recently designated the “chemokine” superfamily. Recent evidence indicates that, contrary to previously held beliefs, IL-8 and Gro-α may not be perceived equivalently by neutrophils. In this study, we have evaluated the effects of IL-8 and Gro-α on the rate of calcium influx in human neutrophils and in 293 cells transfected with type A or type B IL-8 receptors. Of these two chemokines, only Gro-α induced an influx of calcium in neutrophils as judged by the sensitivity of the mobilization of calcium to the extracellular calcium chelator EGTA and to the nonselective divalent cation channel inhibitor SK&F 96365, as well as by manganese quenching experiments. IL-8 was similarly without effect on the rate of Mn2+ influx in 293 cells transfected with IL-8 receptor A (IL-8RA) or IL-8RB. On the other hand, Gro-α induced an SK&F 96365-sensitive increase of the rate of Mn+2 influx in IL-8RB-, but not in IL-8RA-transfected 293 cells. These results indicate not only that neutrophils respond differently to IL-8 than they do to Gro-α but, furthermore, that the consequences of the binding of IL-8 and Gro-α to IL-8RB are distinct.


Journal of Immunology | 1994

Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin-induced pleurisy.

V. C. Broaddus; A. M. Boylan; J. M. Hoeffel; Kyung Jin Kim; M. Sadick; Anan Chuntharapai; Caroline Hebert


Journal of Biological Chemistry | 1994

Complete mutagenesis of the extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged residues mediating IL-8 binding and signal transduction.

S R Leong; R C Kabakoff; Caroline Hebert


Archive | 1994

Antibodies to human IL-8 type B receptor

Anan Chuntharapai; Caroline Hebert; Kyung Jin Kim; James Lee


Cancer Investigation | 1993

Interleukin-8: A Review

Caroline Hebert; Joffre Baker


Journal of Biological Chemistry | 1993

Partial functional mapping of the human interleukin-8 type A receptor. Identification of a major ligand binding domain.

Caroline Hebert; Anan Chuntharapai; M. Smith; T. Colby; Jin K. Kim; R. Horuk


Cytokine | 2001

ADAPTING PHARMACOKINETIC PROPERTIES OF A HUMANIZED ANTI-INTERLEUKIN-8 ANTIBODY FOR THERAPEUTIC APPLICATIONS USING SITE-SPECIFIC PEGYLATION

Steven R. Leong; Laura DeForge; Leonard G. Presta; Tania Gonzalez; Audrey Fan; Marcel Reichert; Anan Chuntharapai; K. Jin Kim; Daniel Tumas; Wyne P. Lee; Peter Gribling; Brad Snedecor; Han Chen; Vanessa Hsei; Monika B. Schoenhoff; Victoria Hale; James Deveney; Iphigenia Koumenis; Zahra Shahrokh; Patrick McKay; Walter Galan; Brian Wagner; Daljit S. Pleasanton Narindray; Caroline Hebert; Gerardo A. Zapata


Archive | 1995

Anti-il-8 monoclonal antibodies for treatment of inflammatory disorders

Claire M. Doerschuk; Sherman Fong; Caroline Hebert; Kyung Jin Kim; Steven R. Leong


Protein Science | 2008

Monomeric variants of IL‐8: Effects of side chain substitutions and solution conditions upon dimer formation

Henry B. Lowman; Wayne J. Fairbrother; Paul H. Slagle; Rhona C. Kabakoff; Jun Liu; Steven J. Shire; Caroline Hebert

Collaboration


Dive into the Caroline Hebert's collaboration.

Researchain Logo
Decentralizing Knowledge